1. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma
   Yuki Shimoda et al, 2018, BMC Cancer CrossRef
2. Resveratrol promotes oxidative stress to drive DLC1 mediated cellular senescence in cancer cells.
   Shuhua Ji et al, 2018, Exp Cell Res CrossRef
3. Measuring Activity of Native Plant Sirtuins - The Wheat Mitochondrial Model
   Mario Soccio et al, 2018, Front. Plant Sci. CrossRef
4. Reactive Oxygen Species and p53 Mediated Activation of p38 and Caspases is Critically Involved in Kaempferol Induced Apoptosis in Colorectal Cancer Cells
   Jhin-Baek Choi et al, 2018, J. Agric. Food Chem. CrossRef
5. The effect of lentivirus-mediated SIRT1 gene knockdown in the ATDC5 cell line via inhibition of the Wnt signaling pathway
   Yu Fei et al, 2018, Cellular Signalling CrossRef
6. Inhibition of NF-κB Signaling Pathway by Resveratrol Improves Spinal Cord Injury.
   Luyao Xu et al, 2018, Front Neurosci CrossRef
7. Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine
   Debashri Manna et al, 2018, J Mol Model CrossRef
8. Resveratrol improves ex vivo expansion of CB-CD34+ cells via downregulating intracellular reactive oxygen species level
   Chaochun Tang et al, 2018, J Cell Biochem CrossRef
9. Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer
   Xiaoxia Jin et al, 2019, Cancer Med CrossRef
10. Encapsulation of resveratrol in zein/pectin core-shell nanoparticles: Stability, bioaccessibility, and antioxidant capacity after simulated gastrointestinal digestion
    Xulin Huang et al, 2019, Food Hydrocolloids CrossRef
11. The Roles of Natural Compounds in Epigenetics
    Yanhong Yang et al, 2018, Natural Product Communications CrossRef
12. Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells
    Evren Önay Uçar et al, 2019, Cell Stress and Chaperones CrossRef
13. Resveratrol decreases TNFα-induced ICAM-1 expression and release by Sirt-1-independent mechanism in intestinal myofibroblasts
    Vladana Domazetovic et al, 2019, Experimental Cell Research CrossRef
14. Resveratrol Activates Autophagy via the AKT/mTOR Signaling Pathway to Improve Cognitive Dysfunction in Rats With Chronic Cerebral Hypoperfusion
    Nan Wang et al, 2019, Front. Neurosci. CrossRef
15. Nrf2–Keap1 pathway–mediated effects of resveratrol on oxidative stress and apoptosis in hydrogen peroxide–treated rheumatoid arthritis fibroblast‐like synoviocytes
    Ye Zhang et al, 2019, Ann. N.Y. Acad. Sci. CrossRef
16. BZD9L1 sirtuin inhibitor as a potential adjuvant for sensitization of colorectal cancer cells to 5-fluorouracil
    Yi Jer Tan et al, 2019, Ther Adv Med Oncol CrossRef
17. A tumor suppressor DLC1: The functions and signal pathways
    Yang Zhang et al, 2019, J Cell Physiol CrossRef
18. A Stilbenoid Isorhapontigenin as a Potential Anti-Cancer Agent against Breast Cancer through Inhibiting Sphingosine Kinases/Tubulin Stabilization
    Lalita Subedi et al, 2019, Cancers CrossRef
19. Signaling Network of Forkhead Family of Transcription Factors (FOXO) in Dietary Restriction
    Yizhou Jiang et al, 2019, Cells CrossRef
20. A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications
    Dan-Dan Huang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
21. Research Progress on Alzheimer's Disease and Resveratrol
    Yan Yan et al, 2020, Neurochem Res CrossRef
22. Exendin‐4 exhibits a tumour suppressor effect in SKOVR‐3 and OVACR‐3 ovarian cancer cells lines by the activation of SIRT1 and inhibition of NF‐κB
    Eman F. Khaleel et al, 2020, Clin Exp Pharmacol Physiol CrossRef
23. Pyrazinamide enhances lipid peroxidation and antioxidant levels to induce liver injury in rat models through PI3k/Akt inhibition
    Yun Xu et al, 2020 CrossRef
24. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved
    Peng Bian et al, 2020, Archives of Biochemistry and Biophysics CrossRef
25. Resveratrol inhibits oral squamous cell carcinoma cells proliferation while promoting apoptosis through inhibition of CBX7 protein
    Ling Chen et al, 2020, Environmental Toxicology CrossRef
26. miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA.
    Shengping Zhang et al, 2018, Exp Ther Med CrossRef
27. Effect of SIRT1 activators and inhibitors on CD44+/CD133+‑enriched non‑small cell lung cancer cells
    Zuhal Eroglu et al, 2020, Mol Med Report CrossRef
28. miRNA-20b inhibits cerebral ischemia-induced inflammation through targeting NLRP3
    Jingru Zhao et al, 2018, Int J Mol Med CrossRef
29. Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling
    Hanhan Dai et al, 2020, Aging CrossRef
30. Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.
    Sara Verdura et al, 2020, Aging (Albany NY) CrossRef
31. Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma
    Xixi Tian et al, 2020, The Journal of Nutritional Biochemistry CrossRef
32. Resveratrol exerts antitumor effects by downregulating CD8+CD122+ Tregs in murine hepatocellular carcinoma
    Qunfang Zhang et al, 2020, OncoImmunology CrossRef
33. null
    Zi-Lin Li et al, 2020 CrossRef
34. Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration via regulation of the DLC1/TCTP/Cdc42 pathway
    Junying Gao et al, 2020, Food Funct. CrossRef
35. A New Twist in Protein Kinase B/Akt Signaling: Role of Altered Cancer Cell Metabolism in Akt-Mediated Therapy Resistance.
    Isabell Götting et al, 2020, Int J Mol Sci CrossRef
36. Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways
    Francesca Benedetti et al, 2020, Viruses CrossRef
37. AKT as a Therapeutic Target for Cancer.
    Mengqiu Song et al, 2019, Cancer Res CrossRef
38. CK2 Down-Regulation Increases the Expression of Senescence-Associated Secretory Phenotype Factors through NF-κB Activation
    Junbin Song et al, 2021, IJMS CrossRef
39. Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
    Aranka Brockmueller et al, 2021, Cancers CrossRef
40. Nanophytomedicine Based Novel Therapeutic Strategies in Liver Cancer
    Sachin Kumar et al, 2020, CTMC CrossRef
41. Tumor suppressor gene DLC1: Its modification, interactive molecules, and potential prospects for clinical cancer application
    Guanghui Ren et al, 2021, International Journal of Biological Macromolecules CrossRef
42. A tumorigenic cell line derived from a hamster cholangiocarcinoma associated with Opisthorchis felineus liver fluke infection
    Viatcheslav A. Mordvinov et al, 2021, Life Sciences CrossRef
43. Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling
    Olaf-Georg Issinger et al, 2021, Biomedicine & Pharmacotherapy CrossRef
44. Resveratrol acts via melanoma-associated antigen A12 (MAGEA12)/protein kinase B (Akt) signaling to inhibit the proliferation of oral squamous cell carcinoma cells
    Yu Shang et al, 2021, Bioengineered CrossRef
45. Cytotoxic and Proapoptotic Effects of Resveratrol in In Vitro Studies on Selected Types of Gastrointestinal Cancers
    Katarzyna Ratajczak et al, 2021, Molecules CrossRef
46. Enhanced oral permeability of Trans-Resveratrol using nanocochleates for boosting anticancer efficacy; in-vitro and ex-vivo appraisal
    Mohamed G. El-Melegy et al, 2021, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
47. Targeting of cancer cell death mechanisms by resveratrol: a review
    Xiao Fu et al, 2021, Apoptosis CrossRef
48. Resveratrol protects human luteinised granulosa cells against hydrogen peroxide-induced oxidative injury through the Sirt1
    Zhaoyan Nie et al, 2021, Reprod. Fertil. Dev. CrossRef
49. Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway
    Juhua Zhuang et al, 2018, oncol res CrossRef
50. VLCAD inhibits the proliferation and invasion of hepatocellular cancer cells through regulating PI3K/AKT axis
    QW Zhu et al, 2022, Clin Transl Oncol CrossRef
51. Polygonum cuspidatum inhibits the growth of osteosarcoma cells via impeding Akt/ERK/EGFR signaling pathways
    Jun Zhao et al, 2022, Bioengineered CrossRef
52. DLC1 Is a Prognosis-Related Biomarker Correlated With Tumor Microenvironment Remodeling in Endometrial Carcinoma
    Yalan Wu et al, 2022, Front. Oncol. CrossRef
53. Resveratrol drives cancer cell senescence via enhancing p38MAPK and DLC1 expressions
    Yan Bian et al, 2022, Food Funct. CrossRef
54. Nutrition, metabolism, and epigenetics: pathways of circadian reprogramming
    Tomoki Sato et al, 2022, EMBO Reports CrossRef
55. null
    Zaida Zakaria et al, 2022 CrossRef
56. Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer
    Saleh A. Almatroodi et al, 2022, Molecules CrossRef
57. Applications of resveratrol in the treatment of gastrointestinal cancer
    Mohammad Roshani et al, 2022, Biomedicine & Pharmacotherapy CrossRef
58. Depleting TMED3 alleviates the development of endometrial carcinoma
    Jin Zhang et al, 2022, Cancer Cell Int CrossRef
59. Biological Role of AKT and Regulation of AKT Signaling Pathway by Thymoquinone: Perspectives in Cancer Therapeutics
    Md. Junaid et al, 2021, MRMC CrossRef
60. Disease-associated regulation of gene expression by resveratrol: Special focus on the PI3K/AKT signaling pathway
    Soudeh Ghafouri-Fard et al, 2022, Cancer Cell Int CrossRef
61. Pharmacological Modulation of Apoptosis and Autophagy in Pancreatic Cancer Treatment
    Nityaa Selvarajoo et al, 2022, MRMC CrossRef
62. Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review
    Jung Yoon Jang et al, 2022, IJMS CrossRef
63. Transcription Factors as Targets of Natural Compounds in Age-Related Diseases and Cancer: Potential Therapeutic Applications
    Mi Eun Kim et al, 2022, IJMS CrossRef
64. Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer
    Bhurichaya Innets et al, 2022, Molecules CrossRef
65. null
    Mayela Govea Salas et al, 2022 CrossRef
66. Resveratrol and Its Role in the Management of B-Cell Malignancies—A Recent Update
    Dhruv Sanjay Gupta et al, 2023, Biomedicines CrossRef
67. Resveratrol induces DNA damage-mediated cancer cell senescence through the DLC1–DYRK1A–EGFR axis
    Fengqiu Ma et al, 2023, Food Funct. CrossRef
68. null
    A. de Conti et al, 2019 CrossRef
69. Therapeutic role of resveratrol against hepatocellular carcinoma: a review on its molecular mechanisms of action
    Sanchari Bhattacharya et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef
70. Epigenetics of Sirtuins: Relevance to Hepatocellular Carcinoma
    Xingyu Zhu et al, 2021 CrossRef
71. Effect of the Ruan Jian Qing Mai Recipe on Wound Healing in Diabetic Mice and Prediction of its Potential Targets
    Pei Zhang et al, 2023, CCHTS CrossRef
72. Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence
    Arunaksharan Narayanankutty et al, 2023, PRA CrossRef
73. Design, synthesis, and biological evaluation of 1-styrenyl isoquinoline derivatives for anti-hepatocellular carcinoma activity and effect on mitochondria
    Yuqing Wang et al, 2023, European Journal of Medicinal Chemistry CrossRef